Unlocking the possibilities of BCMA-directed therapies in RRMM: Latest perspectives from IMS and ASH 2025
touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY
Listen to multiple myeloma expert Dr Rakesh Popat review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the International Multiple Society (IMS) and American Society of Hematology (ASH) 2025 congresses. Dr Popat is then joined by fellow experts Dr Paula Rodríguez-Otero and Dr Roberto Mina to discuss the implications of these data for current and future clinical practice.
Overview
Data reviews with Dr Popat
Expert panel discussions with Dr Popat, Dr Rodríguez-Otero and Dr Mina on the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.